Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First GMP Warning Letter Reflects FDA's List Of Major Concerns

This article was originally published in The Tan Sheet

Executive Summary

FDA's first warning letter concerning dietary supplement good manufacturing practices advises Coats International Holdings to follow written procedures, improve documentation and conduct appropriate identity tests
Advertisement

Related Content

GMP Qualification And Testing Provisions Still Trip Supplement Firms
Timely 483 Response Can Ease Agency Enforcement Action – FDA Official
Herbalife's Frankos Sees GMP Challenges In New Light After Leaving FDA
FDA Measures Supplement Firms' GMP Recordkeeping Burden
As Supplement GMP Implementation Hits Zero Hour, Small Firms Still Struggle
Herbalife Touts Vertical Integration As Key To Traceability, Cost Control
FDA's Reynolds Marks Top GMP Trouble Spots As Deadline Looms
FDA's Reynolds Marks Top GMP Trouble Spots As Deadline Looms
FDA Targets Executives With Powerful Misdemeanor Strategy
FDA Will Rev GMP Inspections Of Medium Supplement Firms, After A Pause

Topics

Advertisement
UsernamePublicRestriction

Register

PS104110

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel